• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Amgen (NQ:AMGN)

    272.67 +1.49 (+0.55%)
    Streaming Delayed Price Updated: 3:14 PM EDT, Sep 26, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 997,075
    Open 274.34
    Bid (Size) 272.60 (2)
    Ask (Size) 272.74 (3)
    Prev. Close 271.18
    Today's Range 269.77 - 275.50
    52wk Range 253.30 - 335.88
    Shares Outstanding 537,700,000
    Dividend Yield 3.49%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Amgen Expands US Manufacturing Network Amid New Tariff Policy
    Just when the Trump administration announced a 100% tariff on pharmaceuticals starting in October, Amgen Inc (NASDAQ: AMGN) announced a $650 million expansion of its U.S. manufacturing network. 
    Via Benzinga
    Topics Government World Trade
    Amgen Announces $650M Expansion Of US Manufacturing Network After Trump’s Pharma Tariff Announcement
    Via Stocktwits
    Topics Government

    Performance

    YTD
    +5.2%
    +5.2%
    1 Month
    -5.8%
    -5.8%
    3 Month
    -2.3%
    -2.3%
    6 Month
    -10.8%
    -10.8%
    1 Year
    -12.8%
    -12.8%

    More News

    Read More
    Pharma Tariffs Back In Spotlight On New Trump Threat
    Via Investor's Business Daily
    Topics ETFs Government World Trade
    The Analyst Verdict: Amgen In The Eyes Of 8 Experts
    Via Benzinga
    Trump's 100% Pharmaceutical Tariff: The $270 Billion Manufacturing War That Could Reshape Your Medicine Cabinet
    Via Benzinga
    Topics Government World Trade
    How Is The Market Feeling About Amgen?
    Via Benzinga
    European Advisory Panel Recommends Two AstraZeneca Drugs For Approval
    Via Benzinga
    Big Pharma's Epicenter Shift: Eli Lilly and the Reshaping of the Weight-Loss Drug Market
    Via MarketMinute
    Topics Economy Intellectual Property
    Johnson & Johnson's Uninterrupted Dividend Growth: Innovation in Medicine and MedTech Drives Strong Q2 2025 Performance
    Via MarketMinute
    Topics Artificial Intelligence Intellectual Property
    Eli Lilly's Ascent: A New Era in Obesity Treatment Driven by Zepbound and Orforglipron
    Via MarketMinute
    Topics Economy
    The Pharmaceutical Revolution: AI, Gene Therapies, and Obesity Drugs Reshape a Trillion-Dollar Market
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    Why Amgen (AMGN) Stock Is Trading Up Today
    Via StockStory
    Topics Artificial Intelligence
    Friday's session: top gainers and losers in the S&P500 index
    Via Chartmill
    Eli Lilly Poised for Blockbuster Q3 2025 with Skyrocketing EPS and Revenue Projections
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    GLP-1 Titans Clash: Eli Lilly Challenges Novo Nordisk's Dominance in a Spiraling Market Battle
    Via MarketMinute
    Lilly's Oncology Momentum Soars: Olomorasib Gains Breakthrough Status, Jaypirca Achieves Landmark Clinical Successes
    Via MarketMinute
    EMA Backs Amgen Drug For Rare Autoimmune Disorder
    Via Benzinga
    Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
    Via Chartmill
    Uncover the latest developments among S&P500 stocks in today's session.
    Via Chartmill
    The Weight of Progress: A New Era Dawns for Anti-Obesity Drugs, Reshaping Markets and Health
    Via MarketMinute
    2 Healthcare Dividend Stocks to Buy and Hold
    Via The Motley Fool
    Topics Intellectual Property
    The Dawn of a New Era: How GLP-1s, AI, and Robotic Surgery Are Reshaping Healthcare and Investment
    Via MarketMinute
    Topics Artificial Intelligence Bankruptcy Economy
    1 Cash-Producing Stock to Target This Week and 2 Facing Challenges
    Via StockStory
    Amgen Rocatinlimab's Data Shows Potential As Long-Term Therapy For Atopic Dermatitis
    Via Benzinga
    Amgen and Kyowa Kirin Announce Top-Line Results From Rocatinlimab Phase 3 ASCEND Long-Term Extension Study in Adults With Moderate to Severe Atopic Dermatitis
    From Kyowa Kirin
    Via GlobeNewswire

    Frequently Asked Questions

    Is Amgen publicly traded?
    Yes, Amgen is publicly traded.
    What exchange does Amgen trade on?
    Amgen trades on the Nasdaq Stock Market
    What is the ticker symbol for Amgen?
    The ticker symbol for Amgen is AMGN on the Nasdaq Stock Market
    What is the current price of Amgen?
    The current price of Amgen is 272.67
    When was Amgen last traded?
    The last trade of Amgen was at 09/26/25 03:14 PM ET
    What is the market capitalization of Amgen?
    The market capitalization of Amgen is 146.61B
    How many shares of Amgen are outstanding?
    Amgen has 147B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.